An outlook on coronavirus disease 2019 detection methods
Diagnostic testing plays a fundamental role in the mitigation and containment of coronavirus disease 2019 (COVID-19), as it enables immediate quarantine of those who are infected and contagious and is essential for the epidemiological characterization of the virus and estimating the number of infect...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical analysis 2022-04, Vol.12 (2), p.205-214 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Diagnostic testing plays a fundamental role in the mitigation and containment of coronavirus disease 2019 (COVID-19), as it enables immediate quarantine of those who are infected and contagious and is essential for the epidemiological characterization of the virus and estimating the number of infected cases worldwide. Confirmation of viral infections, such as COVID-19, can be achieved through two general approaches: nucleic acid amplification tests (NAATs) or molecular tests, and serological or antibody-based tests. The genetic material of the pathogen is detected in NAAT, and in serological tests, host antibodies produced in response to the pathogen are identified. Other methods of diagnosing COVID-19 include radiological imaging of the lungs and in vitro detection of viral antigens. This review covers different approaches available to diagnosing COVID-19 by outlining their advantages and shortcomings, as well as appropriate indications for more accurate testing.
[Display omitted]
•Diagnostic tests to detect coronavirus disease 2019 (COVID-19).•Advantages and disadvantages associated with each detection method.•Implications for a more accurate and rapid testing of COVID-19 or other similar future emergent viruses. |
---|---|
ISSN: | 2095-1779 2214-0883 |
DOI: | 10.1016/j.jpha.2021.11.003 |